The application of PKI-587, a dual PI3K/mTOR inhibitor, was able to increase DNA damage, enhance G0/G1 cell cycle arrest, induce apoptosis, and increase the radiotherapy sensitivity of HCC [32]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.